✦ LIBER ✦

Survival in proton irradiated uveal melanoma patients: Implications for prospective randomized trials

✍ Scribed by J.E. Munzenrider; E. Gragoudas; J.M. Seddon; P. McNulty; J. Sisterson; K. Johnson; M. Austin-Seymour; S. Birnbaum; R. Gentry; M. Goitein; A.M. Koehler; E. Osborne; D. Ruotolo; H.D. Suit; M. Urano; L. Verhey

Book ID: 103721988
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 108 KB
Volume: 12
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(86)90560-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Boswellia serrata acts on cerebral edema

Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors : A prospective, randomized, placebo-controlled, double-blind pilot trial

✍ Simon Kirste; Markus Treier; Sabine Jolie Wehrle; Gerhild Becker; Mona Abdel-Taw 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 1 views

Prospective Preference Assessment of Pat

Prospective Preference Assessment of Patients' Willingness to Participate in a Randomized Controlled Trial of Intensity Modulated Radiotherapy versus Proton Therapy for Localized Prostate Cancer

✍ A. Shah; J.A. Efstathiou; J.J. Paly; S.D. Halpern; J.P. Christodouleas; C. Devil 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Prospective Preference Assessment of Pat

Prospective Preference Assessment of Patients' Willingness to Participate in a Randomized Controlled Trial of Intensity-Modulated Radiotherapy Versus Proton Therapy for Localized Prostate Cancer

✍ Anand Shah; Jason A. Efstathiou; Jonathan J. Paly; Scott D. Halpern; Deborah W. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 434 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Systemic chemotherapy following non-cura

Systemic chemotherapy following non-curative resection may increase survival for people with gall bladder carcinoma, but not carcinomas of the pancreas, bile duct or ampulla of Vater: Abstracted from: Takada T, Amano H, Yasuda H et al. Is postoperative adjuvant chemotherapy useful for gall bladder carcinoma? A phase III multicentre prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 2002; 95(8): 1685–95.

✍ Kazuhiro Hanazaki 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 66 KB